Thomas B. Campbell, M.D.
CURRICULUM VITAE
PERSONAL HISTORY
Name:Thomas B. Campbell, M.D.
Current Position:Professor of Medicine
Division of Infectious Diseases
Department of Medicine
University of ColoradoDenverSchool of Medicine
Address:Mail Stop 8205, Room L15-7421
University of ColoradoDenver
12631 East 17th Avenue
Aurora,CO 80045
Telephone:303-724-4929
Fax:303-724-4926
Email:
EDUCATION
1980Bachelor of Science (Microbiology) magna cum laude,TexasA&MUniversity
1981Master of Science (Microbiology) TexasA&MUniversity
1985Doctor of Medicine,University of Texas Southwestern MedicalSchool
1985-1986Intern in Medicine,University of Texas Southwestern Medical School/Parkland Memorial Hospital
1986-1987Junior Assistant Resident in Medicine, University of Texas Southwestern Medical School/Parkland Memorial Hospital
1987-1988Senior Assistant Resident in Medicine, University of Texas Southwestern Medical School/Parkland Memorial Hospital
1990-1993Clinical and Research Fellow in Medicine, Division of Infectious Diseases,
University of ColoradoDenver
1993-1995Postdoctoral Research Associate, Department of Chemistry and Biochemistry,University of ColoradoBoulder
ACADEMIC APPOINTMENTS
1995-2002Assistant Professor of Medicine,University of ColoradoDenverSchool of Medicine, Aurora, Colorado
1999Assistant Professor of Chemistry and Biochemistry (special appointment),University of Colorado,Boulder,Colorado
1996-2002Assistant Professor of Biochemistry and Molecular Genetics, University of ColoradoDenverSchool of Medicine,Aurora,Colorado
2000-2002Assistant Professor of Microbiology,University of ColoradoDenverSchool of Medicine,Aurora,Colorado
2002-2009Associate Professor of Medicine and Microbiology, University of ColoradoDenverSchool of Medicine,Aurora,Colorado
2008-2014Interim Head, Division of Infectious Diseases, University of Colorado Denver School of Medicine,Aurora,Colorado
2009-presentProfessor of Medicine and Microbiology, University of Colorado Denver School of Medicine,Aurora,Colorado
PROFESSIONAL POSITIONS
1988-1990Physician, Internal Medicine,Colorado SpringsMedicalCenter,
Colorado Springs,Colorado
1993Scientific Advisory Board, Ribozyme Pharmaceuticals, Inc.,Boulder,Colorado
1995-presentAttending Physician, University of Colorado Hospital, Aurora Colorado
1995-2005Attending Physician, Denver Veteran’s AdministrationHospital
2005Clinical Advisory Board, Tanox, Inc., Houston
2008-presentMedical Director, University of Colorado Hospital Clinical Translational Research Center and Clinical Trials Office, Colorado Clinical and Translational Sciences Institute
AWARDS AND HONORS
1976-1977Selby Foundation Scholarship
1979O.B. Williams Award for Meritous Scientific Achievement,Texas Branch of the American Society for Microbiology
1979-1980Undergraduate Senior Honors Program,TexasA&MUniversity
1980-1981Robert A. Welch Predoctoral Fellowship
1992-1993National Research Service Award (Individual), United States Public Health Service
1993-1998Physician Scientist Award (Individual), United States Public Health Service.
2008Fellow of the AmericanCollege of Physicians
2012U.S. News and World Report Top Doctors
2013Award for Excellence in Global Health, University of Colorado Center for Global Health
PROFESSIONAL ORGANIZATION MEMBERSHIP
1992International AIDS Society
2008AmericanCollege of Physicians
COMMITTEE AND SERVICE RESPONSIBILITIES
A. Infectious Disease Division,University of ColoradoDenver
1996-2003Director, Gilman AIDS Research Laboratory,
1999-2003Health and Safety Compliance Coordinator
1999-2004Director,Division of Infectious Diseases International Scholars Program
2004-presentPrincipal Investigator, Colorado AIDS Clinical Trials Unit
2006-2007Chair, Faculty Search Committee
2007-2008Infectious Disease Division Executive Committee
2007Division Administrator Search Committee
B. Department of Medicine,University of ColoradoDenver
2005-presentDepartment of Medicine Intern Selection Committee
2006-2007Endocrinology Division Head Search Committee
2014-2015Section of Infectious Diseases, Department of Pediatrics, Section Head Search Committee
C. School of Medicine,University of ColoradoDenver
2001-2003Medical Scientist Training Program Admissions Committee
2001-2003Dean’s Physician Education Task Force
2003-2008Director,ColoradoCenter for AIDS Research Virology Core Laboratory
2004-2008Associate Program Director, Adult General Clinical ResearchCenter
2004-2008General Clinical Research Advisory Committee,University of Colorado Adult General Clinical ResearchCenter
2006-2008Dean’s Strategic Initiative Review Committee
2006-2010Chair (2008-2010), Dean’s Distinguished Advisory Committee
2008-2010Director,ColoradoCenter for AIDS Research
D. University of ColoradoDenver
1997-98Ad Hoc Reviewer, Institutional Biosafety Committee,University of ColoradoDenver
1998-2006Environmental Health and Safety Committee
1999-presentInstitutional Biosafety Committee (Chair 1999-2010)
2008-presentParticipant and Clinical Interactions Resources Oversight Committee, Colorado Clinical and Translational Sciences Institute
2015-Executive Committee, Center for Global Health, University of Colorado Denver
E. National and International Committees and Workshops
1997Session Chair,Colorado Biotechnology Symposium,Boulder,Colorado
1998Invited Speaker, Novel Treatment Concepts in HIV Therapies Workshop, 4th International Congress on Drug Therapy in HIV Infection,Glasgow,UK
2001-2003HIV Prevention Trials Network Protocol 052 Subcommittee, Adult AIDS Clinical Trials Group, National Institute of Allergy and Infectious Disease
2001-2004Virology Subcommittee, Adult AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases
2002Joint Sino/US Collaboration on Clinical Research and Training, National Institute of Allergy and Infectious Disease
2003International Scientific Agenda Working Group, Adult AIDS Clinical Trials Group, National Institute of Allergy and Infectious Disease
2003World Health Organization Workshop on Ethical Issues in Clinical Trials of Antiretroviral Therapy in Resource Limited Settings,Geneva,Switzerland
2004Session Chair, Salvage Therapy II Think Tank,Houston,Texas
2004-presentAdvisory Board, Zimbabwe AIDS Treatment Assistance (ZATA) Project
2005-2009KS Working Group, AIDS Malignancy Consortium, National Cancer Institute
2005-2009International Working Group, AIDS Malignancy Consortium, National Cancer Institute
2005-presentExecutive Committee,University of Zimbabwe Clinical Trials Unit
2007Invited participant, Oral HIV/AIDS Research Alliance investigators meeting,Durham,NC
2007-2008Co-chair, AIDS-KS Working Group of the Optimization of Co-Infection and Co-Morbidity Management Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Disease
2010Invited participant, NIMH Workshop: Strategies for Expanding Collaboration with the ACTGTo Advance NeuroAIDS Therapeutics, National Institute of Mental Health
2011-2012Chair, Clinical Working Group, Lung HIV Microbiome Project, National Heart Lung and Blood Institute
2011-2014; 2016-Executive Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Disease
2014Chair, Confidential Information Working Group of the Executive Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Disease
2014Co-chair, Exercise Focus Group of the Inflammation and Comorbidities Transformative Science Group, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Disease
PROFESSIONAL CERTIFICATION
1986-1993Texas State Board of Medical Examiners
1988-presentColorado State Board of Medical Examiners
1988-presentAmerican Board of Internal Medicine, Internal Medicine
1992-2002American Board of Internal Medicine, Infectious Diseases
REVIEW AND REFEREE WORK
A. Scientific Review Committees
2000-2007Cancer Seed Grant Review Committee, University of ColoradoCancerCenter
2002Special Emphasis Panel/Scientific Review Group for “Comprehensive International Program of Research on AIDS (CIPRA), National Institute of Allergy and Infectious Diseases
2004-2008Scientific Advisory Committee, Adult General Clinical Research Center,University of Colorado Denver School of Medicine
2004Special Emphasis Panel/Scientific Review Group for program project grant in HIV recombination, National Institute of Allergy and Infectious Diseases
2004-presentStudy Monitoring Committee,University of Colorado Hospital Clinical Translational Research Center,University of Colorado Denver School of Medicine
2004-2007Optimization of Antiretroviral Therapy Scientific Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases
2005-2008Strategic Initiative Review Committee, University of ColoradoDenverSchool of Medicine
2007Evaluation Committee for Chancellors’ Bridge Funding Awards,University of ColoradoDenver
2007-2011Scientific Agenda Steering Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases
2008-presentScientific Advisory and Review Committee, Colorado Clinical and Translational Sciences Institute
2008-presentStudy Monitoring Committee, Colorado Clinical and Translational Sciences Institute
2008Special Emphasis Panel/Scientific Review Group for International Clinical, Operations and Health Services Research Training Awards for AIDS and TB, National Institute of Allergy and Infectious Diseases
2008Special Emphasis Panel/Scientific Review Group for AIDS International Training and Research Program, National Institute of Allergy and Infectious Diseases
2008Abstract Review Committee, 2009 Western Regional Meeting,Carmel,CA
2007-2011Optimization of Co-Infection and Co-Morbidity Management Scientific Committee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases (Vice Chair 2007-2009, Chair 2009-2011)
2010Special Emphasis Panel/Scientific Review Group for Methods for Prevention Packages (MP311) R01, National Institute of Allergy and Infectious Diseases
2011Panel for Review of Infections and Immunoepidemiology Branch, National Cancer Institute
2011-2014Co-infections and Malignancies Subcommittee, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases
2011-2015Neurology Collaborative Science Group, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases
2011-2012Independent Safety Monitor, “An Open Label Study in Adults with Atopic Dermatitis to Assess Variability in Immune Response to Fluzone® Intradermal Vaccine,” National Institute of Allergy and Infectious Diseases
2011-2017Chair, Safety Monitoring Committee for ACTG study “A5225/HiFLAC, A Phase I/II Dose-Finding Study of High-Dose Fluconazole Treatment in AIDS-Associated Cryptococcal Meningitis,” National Institute of Allergy and Infectious Diseases
2012-2013Independent Safety Monitor, "A Randomized Open Label Mechanistic Study in Atopic Dermatitis to Assess the Immunogenicity of Fluzone® Intradermal and Intramuscular Vaccines (ADRN- 05)" National Institute of Allergy and Infectious Diseases
2013-presentAIDS Research Review Committee, National Institute of Allergy and Infectious Diseases
2013External Reviewer, AIDS Malignancy Consortium Laboratories at University of California Los Angeles and University of California San Francisco
2014Chair, AIDS Research Review Committee Independent Special Emphasis Panel, National Institute of Allergy and Infectious Diseases
2014-2015Data and Safety Monitoring Board for HIPC-VAX-010: Systems Biology of Influenza A (H5N1) Virus Monovalent Vaccine with and without AS03 adjuvant, National Institute of Allergy and Infectious Diseases
2014-2017Antiretroviral Therapy Transformative Science Group, AIDS Clinical Trials Group, National Institute of Allergy and Infectious Diseases
2015-presentNational Institute of Allergy and Infectious Diseases Transplant Data and Safety Monitoring Board (ad hoc member for HIV trials)
2017PEER/Liberia Review Panel, National Academies of Science, Engineering and Medicine, Washington, D.C.
2017External Reviewer, AIDS Malignancy Consortium Laboratories at University of California Los Angeles and University of California San Francisco
2017Medical Monitor, “PanBlok® H7 Influenza at Three Dose Levels Adjuvanted with AS03 and MF59”, Biomedical Advanced Research and Development Authority (BARDA), Washington, D.C.
B. Journal Referee
1996Ad hoc reviewer for RNA
1999-presentAd hoc reviewer for Clinical and Diagnostic Laboratory Immunology,Journal of Infectious Diseases,Blood,Antiviral Therapy, Journal of Virology, AIDS Research and Human Retroviruses, Journal of Virological Methods, Molecular Therapy and Genomics, JAIDS,Journal of Clinical Virology, Clinical Infectious Diseases, PLOS One, Academic Medicine
INVITED EXTRAMURAL LECTURES AND PRESENTATIONS
1992St. Mary’s Hospital Continuing Medical Education Program, “HIV Virology,” St. Mary’s Hospital, Grand Junction, Colorado
1994JohnsHopkinsUniversitySchool of Medicine Cancer Therapy Program, "Ribozymes as Antiretroviral Agents," JohnsHopkinsUniversity,Baltimore,Maryland
1996Biology Seminar Series, "Catalytic RNA as a Therapeutic: Problems and Promises," TrumanStateUniversity,Kirksville,Missouri
1997Molecular Biology Seminar Series, "The Effect of Structure in a Long Substrate RNA on Ribozyme Cleavage Efficiency," Beckman Research Institute of the City of Hope,Duarte,California
199834th Annual Internal Medicine Program, "Treatment of HIV in 1998," Estes Park,Colorado
1998Progress in Medicine Seminar Series, "The Role of Human Herpesvirus 8 in Kaposi's sarcoma," University of Zimbabwe School of Medicine,Harare,Zimbabwe
1998World Health Communications Continuing Medical Education Program: Comprehensive Management of HIV Disease, “Human Herpesvirus 8 as a Cause of HIV-Related Malignancies,” Boca Raton,Florida
1999Department of Pathology Research Seminar Series, "Human Herpesvirus 8 and the Pathogenesis of Kaposi's Sarcoma and Other Malignancies," School of Veterinary Medicine,ColoradoStateUniversity,Fort Collins,Colorado
1999Second Workshop Related to HIV/AIDS in China, "Human Herpesvirus 8: Role in Kaposi's Sarcoma," ChineseAcademy of Medical Sciences,Beijing,China
1999World Health Communications Continuing Medical Education Program: Protease Inhibitors in Practice: Myth vs Reality, “Resistance Issues Affecting Protease Inhibitor Therapy,” Coral Gables,Florida
2000NIH Symposium on the Biology of the Skin, “Molecular Approaches to Treatment of Infectious Diseases,” Snowmass,Colorado
2000NIH Symposium on the Biology of the Skin, “Human Herpesvirus 8 and KS Pathogenesis,” Snowmass,Colorado
2000University of Colorado Outreach Program, “Update on HIV Pathogenesis and Treatment,” CampbellCountyMemorialHospital,Gillette,Wyoming
2001Challenges in Infectious Diseases – 2001, “HIV in Primary Care,” LDSHospital,Salt Lake City,Utah
2001Progress in Medicine Seminar Series, "KSHV Replication and KS Disease,” University of ZimbabweSchool of Medicine,Harare,Zimbabwe
2001University of Colorado Outreach Program, “Update on HIV Pathogenesis and Treatment,” MontroseMemorialHospital,Montrose,Colorado
2002University of Colorado CME Program “Resistance Education,” Beverly Hills,CA
2002University of Colorado CME Program “Resistance Education,” World Wide Web conferences
2003University of Colorado CME Program “Resistance Education,” Beverly Hills,CA
2003University of Colorado CME Program “Resistance Education,” Great Neck, NY
2003Medical Grand Rounds “Insights into the Kaposi’s Sarcoma Epidemic in Southern Africa”,University of California,San Francisco
2003Association of Public Health Laboratories Infectious Disease Conference, “Molecular Methods for the Detection and Quantitation of HHV-8 (KSHV) Infection,” Denver,Colorado
2004Bugs and Drugs Symposium, “HIV Update”,Denver,Colorado
2004-presentSemi-annual Community Update on HIV Research, Colorado AIDS Education and TrainingCenter,Denver,Colorado
2004Shadow Cliff Retreat, “HIV 101”,Grand Lake,Colorado
2004“The AIDS Epidemic in Africa: How Clinical Research Can Make a Difference”, Infectious Disease Division,WashingtonUniversityMedicalSchool,St. Louis,Missouri
2005Shadow Cliff Retreat, “HIV Treatment Update”,Grand Lake,Colorado
200622nd Annual Clinical Virology Symposium, “The Global Impact of Therapy on HIV/AIDS”,Clearwater Beach,Florida
2006Shadow Cliff Retreat, “HIV Treatment 2006”,Grand Lake,Colorado
2006African Institute of Biomedical Science and Technology, “AIDS-KS in Zimbabwe”,Harare,Zimbabwe
2006Invited Discussant, Community Benefits in International Research Panel, 8th Annual Meeting of the American Society for Bioethics and Humanities,Denver
2007Session Co-chair, African International Conference on Immunity,Victoria Falls,Zimbabwe
2007Shadow Cliff Retreat, “New HIV Drugs and Treatment Strategies”,Grand Lake,Colorado
2007Plenary Speaker, “Baseline Analysis in the ACTG study to Prospectively Evaluate Antiretroviral Therapy in Resource-Limited Settings (PEARLS).” Annual Meeting of the AIDS Clinical Trials Group,Washington,D.C.
2008Shadow Cliff Retreat, “HIV Treatment 2008”,Grand Lake,Colorado
2008Plenary Speaker, “A DSMB Finding in the ACTG study to Prospectively Evaluate Antiretroviral Therapy in Resource-Limited Settings (PEARLS).”Annual Meeting of the AIDS Clinical Trials Group,Washington,D.C.
2009Plenary Speaker, “The PEARLS Study, a Multinational Clinical Trial of HIV Treatment,”Harvard Schering-Plough 17th Annual Workshop, Harvard School of Public Health,Boston,MA.
2009Shadow Cliff Retreat, “HIV Update: 10 Questions,” Grand Lake,Colorado
2009Plenary Speaker, “Globalization of Antiretroviral Therapy,” Annual Meeting of the Rocky Mountain Virology Club, Pingree Park, Colorado
2009Plenary Speaker, “Clinical and Virological Outcomes of Antiretroviral Therapy for AIDS-Related Kaposi’s Sarcoma in Zimbabwe,” U.S. Military HIV Research Program Site Investigator Meeting,Chiang Mai,Thailand.
2010Shadow Cliff Retreat, “HIV Treatment 2010”, Grand Lake,Colorado
2010Plenary Speaker, “AIDS-KS in Zimbabwe,” Annual Research Conference, UZ-UCSF Collaborative Research Programme in Women’s Health, Harare, Zimbabwe.
2011Shadow Cliff Retreat, “Ten Hot Topics in HIV Care”, Grand Lake, Colorado
2012Plenary Speaker, "Choosing the 1st regimen-results from ACTG A5175", Chennai ART Symposium, Chennai, India
2012Internal Medicine Grand Rounds, "Globalization of Antiretroviral Therapy", Exempla Saint Joseph Hospital, Denver, Colorado
2012MEPI Grand Rounds, "Globalization of Antiretroviral Therapy", Nelson Mandela Medical School, Durban, South Africa
2013Plenary Speaker, "Role of New Drugs in 1st Line HAART Regimens", Chennai ART Symposium, Chennai, India
2013Plenary Speaker, "Complications of Tenofovir", Chennai ART Symposium, Chennai, India
2014Plenary Speaker, "Management of Treatment Experienced Patients:
3rd line regimens", Chennai ART Symposium, Chennai, India
2014Plenary Speaker, "Inflammation and Immune Activation: Results from the PEARLS study", Chennai ART Symposium, Chennai, India
2014Keynote Speaker, "Global perspective on HIV/AIDS: Scientific advances: Is an end to the epidemic achievable?", US-Georgia Program Development Workshop on HIV/AIDS, Tuberculosis and Hepatitis, Tbilisi, Georgia
2014Shadow Cliff Retreat, “Ten things about HIV/AIDS that everyone should know”, Grand Lake, Colorado
2014Invited speaker, "Kaposi's Sarcoma in Zimbabwe", Department of Internal Medicine, Universidade Eduardo Mondlane, Maputo, Mozambique
2014Plenary Speaker, "Options for 3rd line ARV therapy in the developing world", MEPI Clinical HIV Symposium, University of KwaZulu Natal, Durban, South Africa
2014Plenary Speaker, "Closing Gaps in the Management of Kaposi’s Sarcoma", HIV and TB Care in South Africa Conference, Durban, South Africa
2015Plenary Speaker, "Newer ARVS: When to use them?", Chennai ART Symposium, Chennai, India
2015Plenary Speaker, "Inflammation and Immune Activation: Results from the PEARLS sub-studies", Chennai ART Symposium, Chennai, India
2016Shadow Cliff Retreat, “Ten things about HIV/AIDS that everyone should know”, Grand Lake, Colorado
2016“Contemporary Management of HIV-Antiretroviral Therapy: When to Start, What to Start.”Albert Einstein College of Medicine CME program, Scottsdale, AZ.
2016“Updates from AIDS 2016”Albert Einstein College of Medicine CME program, Denver, CO.
2017Plenary Speaker, “Role of dolutegravir in resource-limited settings”, Chennai ART Symposium, Chennai, India
2017Plenary Speaker, “Long-acting Injectable Antiretrovirals for Treatment”, Chennai ART Symposium, Chennai, India
2017“Contemporary Management of HIV- Management of Antiretroviral Therapy in Aging Patients.”Albert Einstein College of Medicine CME program, Washington, D.C.
2017“Contemporary Management of HIV-Modifying Antiretroviral Therapy in Virologically Suppressed Patients and Those with Treatment Failure.” Albert Einstein College of Medicine CME program, New Orleans, LA.
2017“Contemporary Management of HIV-HIV Therapies in Advanced Clinical Development.” Albert Einstein College of Medicine CME program, Miami, FL.
TEACHING RECORD
A. Classroom Instructional Activities
1980Graduate Teaching Assistant, Introduction to Microbiology Laboratory,TexasA&MUniversity
1991-1992Assistant Small Group Leader, Infectious Disease Pathophysiology, University of ColoradoDenverSchool of Medicine
1995-presentLecturer, Fundamentals of Infectious Diseases Course, ID Division, University of Colorado Denver School of Medicine,one to two lectures per year
1996-2004Group Leader, Second Year Medical Student Infectious Disease Pathophysiology, University of Colorado Denver School of Medicine, five sessions per year
1999-2010Lecturer, Molecular Virology Course (MICB7627), Department of Microbiology, University of Colorado Denver School of Medicine, two lectures per year
2000-2004Lecturer, First Year Medical Student Biochemistry Course (BMGN 5000), University of Colorado Denver School of Medicine, one lecture per year
2003-2004Preceptor, Foundations of Doctoring I (IDPT5000), University of Colorado Denver School of Medicine, five small group sessions per year
2004-2005Lecturer, Second Year Medical Student Microbiology Course (MICB6000), Department of Microbiology, University of Colorado Denver School of Medicine, one lecture per year